Drug-Related Side Effects and Adverse Reactions: all 449 studies

Page 5 of 5. Open to participants first (77), then studies with results posted, then the rest; newest registration first within each.

• Bleomycin, Etoposide, and Cisplatin in Treating Patients With Metastatic Germ Cell Cancer of the TesticlesCompletedNCT00324298Phase 3
• Antithymocyte Globulin and Sirolimus in Treating Patients With Relapsed Multiple MyelomaCompletedNCT00317798Phase 1
• Implementation and Evaluation of a Medical Reconciliation Protocol at Brigham and Women's HospitalCompletedNCT00296426Not applicable
• Improving Geriatric Drug Safety in Underserved PracticesStatus unknownNCT00277173Not applicable
• Acetylcysteine, Mannitol, Combination Chemotherapy, and Sodium Thiosulfate in Treating Children With Malignant Brain TumorsTerminatedNCT00238173Phase 1
• Statewide Implementation of Electronic Health RecordsCompletedNCT00225576Phase 2
• PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)CompletedNCT00221702Phase 3
• Tc-99m Renography and Cisplatin-induced NephrotoxicityTerminatedNCT00213642
• Cytokines Polymorphisms and Acetaminophen ToxicityCompletedNCT00166608
• Preventing Adverse Drug Events With PatientSiteCompletedNCT00140504Not applicable
• Ice Chips or Saline Mouth Rinse in Reducing or Preventing Mucositis in Patients Receiving Melphalan and Autologous Stem Cell Transplant for Multiple MyelomaCompletedNCT00118339Not applicable
• N2003-01: Irinotecan, Temozolomide, and Cefixime in Treating Young Patients With Recurrent or Resistant NeuroblastomaCompletedNCT00093353Phase 1
• Docetaxel and Cisplatin With or Without Dimesna in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung CancerCompletedNCT00077311Phase 2
• A Test to Predict the Hemolytic Potential of Drugs in G6PD DeficiencyCompletedNCT00076323Not applicable
• Octreotide in Preventing or Reducing Diarrhea in Patients Receiving Chemoradiotherapy for Anal or Rectal CancerCompletedNCT00075868Phase 3
• Sleep, Fatigue, and Dexamethosone in Children With LeukemiaCompletedNCT00075101Phase 3
• Silymarin (Milk Thistle Extract) in Treating Patients With Acute Lymphoblastic Leukemia Who Are Receiving ChemotherapyCompletedNCT00055718Phase 2
• Amifostine and Melphalan in Treating Patients With Primary Systemic Amyloidosis Who Are Undergoing Peripheral Stem Cell TransplantationTerminatedNCT00052884Phase 1
• Ginkgo Biloba: Antidepressant-Induced Sexual DysfunctionCompletedNCT00034021Phase 2
• Combination Chemotherapy After Surgery With or Without Chinese Herbal Therapy to Treat Symptoms in Women With Breast CancerCompletedNCT00028964Phase 1/2
• Chemotherapy Plus Radiation Therapy With or Without Amifostine in Treating Patients With Locally Advanced Cancer of the NasopharynxTerminatedNCT00025298Phase 2
• Triacetyluridine and Fluorouracil Compared With Gemcitabine in Treating Patients With Unresectable Locally Advanced, or Metastatic Pancreatic CancerCompletedNCT00024427Phase 3
• Paclitaxel, Folic Acid, and Lometrexol in Treating Patients With Locally Advanced or Metastatic Solid TumorsStatus unknownNCT00024310Phase 1
• Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and AnemiaCompletedNCT00017004Phase 3
• Patient Profiling and Provider Feedback to Reduce Adverse Drug EventsCompletedNCT00013143Not applicable
• Dexamethasone Followed by Denileukin Diftitox in Treating Patients With Persistent or Recurrent T-Cell LymphomaCompletedNCT00006345Phase 2
• Gemcitabine, Cisplatin, and Amifostine Following Surgery in Treating Patients With Locally Advanced Bladder CancerCompletedNCT00006105Phase 2
• Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00006012Phase 1/2
• Combination Chemotherapy Plus Gene Therapy in Treating Patients With CNS TumorsCompletedNCT00005796Phase 1
• Docetaxel, Cisplatin, and Amifostine in Treating Patients With Advanced Non-small Cell Lung CancerStatus unknownNCT00004264Phase 1/2
• Amifostine, Chemotherapy, and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung CancerCompletedNCT00004176Phase 2
• Growth Factor to Prevent Oral Mucositis in Patients With Hematologic CancerCompletedNCT00004132Phase 2
• Combination Chemotherapy Plus Amifostine in Treating Patients With Advanced CancerStatus unknownNCT00004036Phase 1
• Combination Chemotherapy Plus Amifostine in Treating Children With Malignant Germ Cell TumorsCompletedNCT00003811Phase 2
• Epoetin Alfa in Treating Anemia in Patients Who Are Receiving ChemotherapyCompletedNCT00003600Phase 3
• Amifostine to Prevent Side Effects in Patients Who Are Receiving Chemotherapy and Radiation Therapy for Limited-Stage Small Cell Lung CancerStatus unknownNCT00003583Phase 2
• Amifostine to Treat Side Effects of Treatment in Patients Receiving Radiation Therapy and Cisplatin for Advanced Head and Neck CancerCompletedNCT00003580Phase 2
• Amifostine & High-Dose Combination Chemotherapy in Treating Patients With Acute ML or CMLWithdrawnNCT00003407Phase 2
• Amifostine in Treating Patients With Stage II or Stage III Non-small Cell Lung CancerCompletedNCT00003313Phase 3
• Amifostine Followed by High Dose Chemotherapy in Treating Patients With Hematologic Cancer or Solid TumorsCompletedNCT00003269Phase 2
• Amifostine and Combination Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid LeukemiaCompletedNCT00003268Phase 1
• Amifostine in Treating Patients With Cancer Who Have Neurological Changes Caused by ChemotherapyCompletedNCT00003252Phase 4
• Amifostine Plus Chemotherapy and Radiation Therapy in Treating Patients With Advanced, Unresectable Head and Neck CancerStatus unknownNCT00003251Phase 1/2
• Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid TumorsCompletedNCT00003144Phase 1
• Chemotherapy, Amifostine, and Radiation Therapy in Treating Patients With Non-small Cell Lung CancerCompletedNCT00003089Phase 2
• High-Dose Chemotherapy and Autologous Blood Cell Transplantation in Treating Patients With Primary, Locally Advanced, or Stage IV Breast CancerCompletedNCT00003068Phase 2
• High-Dose Cytarabine Plus Deoxycytidine in Treating With Acute Myelogenous Leukemia or Other Hematologic MalignanciesCompletedNCT00002818Phase 1
• Irinotecan Plus Cyclosporine and Phenobarbital in Treating Patients With Solid Tumors or LymphomaCompletedNCT00002759Phase 1
• 13-Cis Retinoic Acid With or Without Vitamin E for Prevention of Lung CancerCompletedNCT00002586Phase 2

← Drug-Related Side Effects and Adverse Reactions overview